A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants

NCT07108894 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AbCellera Biologics Inc.